Tag Archives: HIV prevention

Can you believe Facebook ads are misleading people about the outcome of a serious HIV prevention drug, putting real lives in imminent danger, health advocates say?

For months, Facebook has faced continuous blowback because of its decision never to fact-check political ads.

However, this week, Facebook is facing a new critique of the ad policy: This challenge is “factually inaccurate advertisements which suggest negative health effects of Truvada PrEP,” according to the letter published Monday on GLAAD’s website.

 Over 50 groups signed the letter, which included in LGBTQ advocacy, health care, and HIV/AIDS prevention, including three groups that directly adviseFacebook on LGBTQ issues: your Rights Campaign, GLAAD, plus the Trevor Project.

At issue is various ads powered using law firms on Facebook the fact that the letter says contain false details about the HIV-prevention drug Truvada.

Truvada has been shown to be highly effective in the show and then in federal testing.

The ads that have lived viewed a lot of times intended to recruit gay and bisexual men who take Truvada. Overall the law and regulations firms running these ads claim the medication has harmful side effects and therefore are in search of Truvada users to join lawsuits from the drug’s maker, Gilead Sciences.

The ads are “deterring at-risk HIV negative people from the leading drug that blocks HIV infections,” the letter says.

Though GLAAD and other groups have pushed Facebook to remove the ads “for months,” according to The Washington Post, the social media giant has refused to do it. The letter is undoubtedly a work to bring public attention to the ads and also their probably dangerous impact.

It’s the most a direct call to action, with exact demands.

It demands that Facebook and Instagram “immediately remove the advertisements,” that Facebook’s advertising policy described around ads that incorporate propaganda, and that the company reviews its current ad policies.

A Facebook representative told Business Insider that it would be was “examining strategies to improve,” but persisted ads don’t violate the platforms’ ad policies, “nor have they been rated false by third-party fact-checkers.”

The corporation did reportedly call HIV patient advocate Peter Staley on Monday, according to a report inside the Washington Blade. Staley declared that Facebook’s director of external affairs, Lindsay Elin, contacted him to say the discussion was ongoing.

Author Resource Box:

Health advocates: Misleading Facebook ads put ‘real people …. https://www.msn.com/en-us/health/other/health-advocates-misleading-facebook-ads-put-real-peoples-lives-in-imminent-danger/ar-BBY2vrL

Could this be a secure method for the Trump administration to end HIV/AIDS?

The Trump administration announced last week a brand new program that will provide HIV prevention medications without charge for uninsured patients. This pre-exposure prophylaxis (or PrEP) drugs are effective in preventing HIV, but with a cost of $2,000 a month, they’re far too expensive for people without insurance. This new program will provide PrEP at no cost for as much as 200,000 uninsured patients. Supporters have lauded this move being a significant step toward President Trump’s intention to end HIV in the United States. Others have criticized it as not going far enough: They would rather the govt expedite generic drug production and lower the price of PrEP. AD Both are missing an important point: Free or reduced-cost drugs may have no impact if patients can’t access them. The rural South is a growing epicenter for HIV, but as the South makes up about most new HIV diagnoses, it has a quarter of all PrEP-providing clinics. In West Virginia, only 27 percent of the state’s rural counties offer any HIV prevention services. In North Carolina, just two considering the state’s 85 local health departments reported to researchers last year they prescribed PrEP. In Mississippi, patients have taken to bring in three or more hours to access the one health center that dispenses 80 percent of all PrEP pills within the state. And that’s when the patient knows to question for PrEP. Only half of most uninsured patients have a regular supply of medical care.

Image result for pre-exposure prophylaxis

Patients are at high risk of contracting HIV are by far less more likely to do so since they often possess by him marginalized communities that have deep distrust considering the medical system. A Centers for Disease Control and Prevention report found that while African Americans account for 44 percent of individuals who would be eligible for PrEP, they make up for only 11 percent among those on PrEP. African American men who have sex with men possess a 1-in-2 lifetime risk of contracting HIV, yet it includes only 26 percent on PrEP (in comparison with 42 percent of the white peers). Without concerted outreach efforts to these vulnerable communities, the promise of free drugs won’t translate to patients taking them.

The administration’s new program covers only medications themselves. The medical appointment to get the prescription isn’t covered, nor are lab tests or ongoing care. CDC guidelines require that patients undergo multiple blood tests before starting PrEP, and after that, regular testing every three months while on it. Regarding the uninsured, these tests cost hundreds of dollars a year and can price patients from PrEP care. Versus giving free medications to certain uninsured people, a more exceptional solution is helping these patients get health insurance. Medicaid already covers 42 percent of adults with HIV (in comparison with 13 percent of the general adult population), and patients on state Medicaid programs receive coverage not only for PrEP and HIV drug therapies but other comprehensive services such as lab testing, care coordination, and community-based services. Admittance to these public insurance programs is essential for prevention. The federal Ryan White program, which funds cities and states to care for low-income people with HIV, supports only those already diagnosed with HIV. It does not help individuals who could be prevented from getting HIV and does not cover PrEP. Expanding Medicaid to those at high risk for HIV would allow them to receive PrEP and insurance for it the other services they need. 

Patients also need more places to access HIV prevention and treatment. An integral access point is clinics funded by the Title X family planning program. Of the 4,000 Title X clinics throughout the country, 90% provide HIV testing, and a third offer PrEP. These clinics serve low-income patients in rural and underserved areas but now are threatened with closure because of Trump administration’s new Title X restrictions. When the Trump administration wants to achieve its aim of eradicating HIV, it is required to end harmful policies for example the Title X gag rule. And instead of dismantling the Affordable Care Act, it should support state-based Medicaid expansion. It is required to remove discriminatory policies for example the conscience rule and the public charge rule that further stigmatize LGBTQ, minority and immigrant populations that already face the best barriers to care. The Trump administration’s free medication program distracts from the real challenges of HIV prevention and treatment. Pills are no panacea when patients can’t access them in the first place, and after that can’t afford the rest of the health care which comes besides treatment. The administration has got the power to fulfill its promise to end the HIV/AIDS epidemic, but it must start with an honest study of its existing policies. Otherwise, it will keep making tiny steps forward against a backdrop of giant steps backward.

Author Resource Box:

A better way for the Trump administration to end HIV/AIDS. https://hagerstownairport.org/2019/12/09/a-better-way-for-the-trump-administration-to-end-hiv-aids/
Quality healthcare services offered for LGBT community in …. https://vietnamnews.vn/society/483418/quality-healthcare-services-offered-for-lgbt-community-in-hcm-city.html

Millions of people in the United States live with HIV

Although HIV/AIDS has mainly faded from the headlines, the disease continues to be infecting millions. When looking at the United States, about 1.1 million people age 13 and older are living with HIV, the virus which causes AIDS, according to the Centers for Disease Control and Prevention. A decade ago, the sheer number of U.S. infections was declining substantially every year, but that stopped in 2013. Since that time, about 39,000 individuals have become newly infected each year, which prompted the CDC this present year to declare the nation’s progress in preventing HIV has stalled. Current commentary by four top public health insurance and AIDS experts, published within the New England Journal of Medicine, reports that a lot more than two-thirds of new infections occur those types of who will be poor or who are ethnic, racial or sexual minorities. The CDC did note locales which have enacted plans to eliminate HIV epidemics within their communities have observed some success in prevention, with new HIV infections down 40 percent in Washington, D.C., and 23 percent in New York City from 2010 to 2016. No cure exists for HIV or AIDS. (AIDS itself will not kill; nonetheless, it allows other diseases to kill.) Nearly 16,000 people into the United States diagnosed with HIV died in 2016, the newest data available. However, antiretroviral therapy — an HIV treatment regimen that has been introduced into the mid-1990s — can keep HIV controlled, preventing it from progressing to AIDS. Individuals who begin this treatment early and take it regularly as recommended can reduce, and possibly eliminate, their odds of transmitting HIV to others and generally can live long healthy lives.


The Big Number: 1.1 million people in the U.S. live with …. https://www.washingtonpost.com/national/health-science/the-big-number-11-million-people-in-the-us-live-with-hiv/2019/05/10/f9f74338-726c-11e9-9eb4-0828f5389013_story.html